Overview

Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy

Status:
Unknown status

Trial end date:
2012-12-01

Target enrollment:

Participant gender:

Summary

Compare efficacy and safety of 10-day triple therapy (rabeprazole, clarithromycin and amoxicillin) plus N-acetylcystein versus 10-day concomitant therapy (rabeprazole, clarithromycin, amoxicillin and metronidazole) for re-eradication for gastric Helicobacter pylori infection.

Phase:

Phase 4

Details

Lead Sponsor:

Buddhist Tzu Chi General Hospital

Treatments:

Acetylcysteine
Clarithromycin
Metronidazole
Rabeprazole